|
|
Volumn 15, Issue 6, 1999, Pages 1239-1243
|
|
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
DNA;
FLUOROURACIL;
LEVAMISOLE;
PROTEIN P53;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
GENETICS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
MUTATION;
PREDICTION AND FORECASTING;
PROGNOSIS;
RECTUM TUMOR;
SINGLE STRAND CONFORMATION POLYMORPHISM;
SURVIVAL;
SURVIVAL RATE;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
CHEMOTHERAPY, ADJUVANT;
DNA, NEOPLASM;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LEVAMISOLE;
MALE;
MIDDLE AGED;
MUTATION;
POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RECTAL NEOPLASMS;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
|
EID: 0033472795
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.15.6.1239 Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
